Contraception (Birth Control) and Family Planning PubHealthInfo

[PubHealth.info Homepage] [Category Homepage] [Disclaimer/Copyrights] [Feedback]

Thank you for your kind visit to PubHealth.info®, an information portal created in technical collaboration with PakMed Biomedical Solutions * * * PubHealth.info® presents hundreds of thousands of informative Web pages on a variety of public health issues / issues * * * An ultimate source of information for teachers, students and research workers who need to find information on various public health issues, like population planning, contraception, HIV AIDS, STDs, maternal and child health, communicable and non-communicable disease, etc. * * * PubHealth.info® regularly updates the repository of these hundreds of thousands of informative Web pages * * * PubHealth.info® is one of the world's largest repositories and information portals with online Web pages on public health issues particularly those pertaining to developing countries!

PubHealth.info® (a subsidiary of PakMed) presents scientific information mainly based on abstracts of articles published on a variety of public health issues/topics, particularly encompassing population planning, disease prevention, maternal and child health, and communicable and non-communicable diseases (like HIV AIDS, malaria, etc) that are affecting a significant portion of population in developing and developed countries. Here you can find abstracts of articles published on a variety of public health topics under category "Contraception (Birth Control) and Family Planning". Contraception (birth control) is a regimen of one or more actions, devices, or medications followed in order to deliberately prevent or reduce the likelihood of a woman becoming pregnant or giving birth. Therefore contraception is the utilization of various and sundry surgical procedures, devices, practices, agents, or drugs with the intention of preventing conception or impregnation (pregnancy). Methods and intentions typically termed birth control may be considered a pivotal ingredient to family planning. Birth control is a controversial political and ethical issue in many cultures and religions, and although it is generally less controversial than abortion specifically.

YEAR: 2004

CATEGORY: Contraception (Birth Control) and Family Planning

TITLE

The combined contraceptive vaginal ring (NuvaRing) and lipid metabolism: a

comparative study.

AUTHORS

Tuppurainen M; Klimscheffskij R; Venhola M; Dieben T

SOURCE

Contraception. 2004 May;69(5):389-394.

ABSTRACT

This study compared the lipid profile after three and six cycles of treatment with NuvaRing delivering 15 µg

ethinylestradiol and 120 µg etonogestrel daily with a combined oral contraceptive (COC) containing ethinylestradiol

30 µg and levonorgestrel 150 µg. In the NuvaRing group 40 women were treated and 43 in the COC group. Compared

with baseline, total cholesterol did not change in either group. NuvaRing did not affect HDL, but HDL, HDL/2 and

HDL/3 levels decreased with the COC. In contrast, HDL/2 increased with NuvaRing at cycle 3. LDL increased after

cycles 3 and 6 with COC, and decreased after three cycles of NuvaRing treatment. Apolipoprotein A-1 levels

increased with NuvaRing, but decreased with COC; apolipoprotein B and triglycerides increased, and lipoprotein(a)

decreased in both groups. Sex hormone-binding globulin increased markedly more with NuvaRing, whereas

corticosteroid-binding globulin levels increased less. These changes reflect the lower androgenicity of etonogestrel

versus levonorgestrel and show that NuvaRing has a minimal effect on lipid profile. (PubHealth.info Document ID:

CONT1T 501-06)

PubHealth.info NOTE: The author(s) of this article titled, "The combined contraceptive vaginal ring (NuvaRing) and

lipid metabolism: a comparative study.", is(are) Tuppurainen M; Klimscheffskij R; Venhola M; Dieben T. The

source of this article is "Contraception. 2004 May;69(5):389-394.". This article was published in 2004 in English

language(s). (PubHealth.info® Document ID: CONT1T 501-06. All rights reserved with PubHealth.info) PIN: 501

This article is peer-reviewed.

This page is optimized to be viewed by Java script enabled Microsoft® Internet Explorer 6 or later version, at screen resolution of 800 by 600 pixels.